Concepedia
4
Publications
786
Citations
H-Index
1997
Active since
Affiliations
Novartis (Switzerland)(Current)
Novartis (Sweden)
Universidade Estadual de Campinas (UNICAMP)
Ulf Vigonius is an author at Novartis (Switzerland) specializing in pharmacotherapy, medicine, and neurology.
Top concepts
MedicineNeurologyPharmacotherapyNeuropharmacologyPsychiatryPediatrics
Publications per year
1997–2013
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
Marilisa M. Guerreiro, Ulf Vigonius, H. Pöhlmann et al. · Epilepsy Research · 1997 · 241 citations
Psychotropic Medication, Oxcarbazepine Versus Phenytoin, Pediatrics +4
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
W. Christe, Günter Krämer, Ulf Vigonius et al. · Epilepsy Research · 1997 · 217 citations
Psychiatry, Psychotropic Medication, Neuropharmacology +3
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
Pierre Alfred Bill, Ulf Vigonius, H. Pöhlmann et al. · Epilepsy Research · 1997 · 215 citations
Psychiatry, Psychotropic Medication, Oxcarbazepine Versus Phenytoin +4
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design
Alla Guekht, Ingmar Skoog, Amos D. Korczyn et al. · Dementia and Geriatric Cognitive Disorders Extra · 2013 · 113 citations · Full text
Rows per page
1–4 of 4